Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 01/31/22
Due: 01/31/23
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 12/31/21
Due: 12/31/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Dose Finding Study of STR-324 | NCT04582786 | Alaxia SAS | user2@example.com | None | 2020-12-01 | 2022-01-31 | 2023-01-31 | - | - | 2025-07-14 |
| Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients | NCT02598999 | Alaxia SAS | user2@example.com | None | 2015-11-30 | 2021-12-31 | 2022-12-31 | - | - | 2025-07-14 |